The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Histopathological challenges in suspected drug‐induced liver injury
Abstract
When a patient with suspected drug‐induced liver injury (DILI) undergoes liver biopsy, the pathologist is confronted with two major challenges. The first and most important is to establish the pattern(s) of injury which are present. Patterns of injury represent stereotypical responses of an organ to injury and relate to specific aetiologies of liver damage. The pattern of injury and the histological details of that injury can then be analysed with respect to the patient's intercurrent diseases and medication history. The specific expertise of the pathologist can be used to weigh the prospect of DILI against the likelihood of other explanations of injury. The second challenge is to characterize specific types of injury and the severity of injury, both of which may have importance for clinical decision‐making and prognosis. The pathologist's report should convey both an accurate description of the pathology as well its interpretation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The histological features of DILI can mimic any hepatic injury pattern and thus, pose a great challenge for pathologists.29,30,31”
From Validation of the revised electronic version of RUCAM for diagnosis of DILI in Chinese patients (2024) · cites this paper as [30]
In the citing paper
“Certain medications are associated with specific histological patterns of liver injury that can be confirmed on biopsy.84”
From AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury (2023) · cites this paper as [84]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Björnsson, E. S., Bergmann, O. M., Björnsson, H. K., Kvaran, R. B., & Olafsson, S. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.02.006 · Cited by 865
Fattinger, K. (2001) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2001.114667 · Cited by 509
Andrade, R. J., Lucena, I. M., Kaplowitz, N., García-Muņoz, B., Borraz, Y., Pachkoria, K., García-Cortés, M., Fernández, C. M., Pelaez, G., Rodrigo, L., et al. (2006) · Hepatology · doi:10.1002/hep.21424 · Cited by 309
Drug-induced autoimmune liver disease: A diagnostic dilemma of an increasingly reported disease
Castiella, A. (2014) · World Journal of Hepatology · doi:10.4254/wjh.v6.i4.160 · Cited by 131
Research works printed but not linked: 63
- 10.1053/j.gastro.2008.09.011 · DOI · Paper page
- 10.1053/jhep.2002.34857 · DOI · Paper page
- 10.1080/00365529850166284 · DOI · Paper page
- 10.3109/00365529509093292 · DOI
- 10.1093/ije/26.4.830 · DOI · Paper page
- 10.1016/j.cgh.2014.07.054 · DOI
- 10.1001/archinte.1965.03860140008003 · doi:10.1001/archinte.1965.03860140008003
- Zimmerman HJ, 2002, Pathology of the Liver, 621
- 10.1002/hep.26709 · DOI · Paper page
- 10.1002/hep.23588 · DOI · Paper page
- 10.1016/j.cgh.2016.05.043 · DOI · Paper page
- 10.1111/liv.13032 · DOI
- 10.1159/000374090 · DOI · Paper page
- 10.1002/hep.26564 · DOI
- 10.1111/j.1365-2222.1982.tb02521.x · DOI
- 10.1021/tx500013z · DOI
- 10.1016/S0016-5085(00)70224-1 · DOI · Paper page
- 10.1016/j.mehy.2016.06.004 · DOI
- 10.1111/j.1365-2036.2007.03330.x · DOI · Paper page
- 10.1016/S0016-5085(99)70356-2 · DOI
- 10.1124/mol.59.3.627 · doi:10.1124/mol.59.3.627 · Paper page
- 10.1097/01.fpc.0000230418.28091.76 · DOI · Paper page
- 10.1002/hep.510280625 · DOI · Paper page
- 10.1016/0168-8278(90)90066-Z · doi:10.1016/0168-8278(90)90066-z
- 10.1038/ajg.2015.283 · DOI · Paper page
- 10.1002/hep.28967 · DOI · Paper page
- 10.1097/PAS.0000000000000802 · DOI
- 10.1016/j.jhep.2010.11.006 · DOI · Paper page
- Trost LC, 1996, The mitochondrial permeability transition: a new pathophysiological mechanism for Reye's syndrome and toxic liver injury, J Pharmacol Exp Ther, 278, 1000, 10.1016/S0022-3565(25)20745-5 · DOI
- 10.1016/S0009-2797(01)00234-4 · doi:10.1016/s0009-2797(01)00234-4
- 10.1016/S0378-4274(98)00097-6 · doi:10.1016/s0378-4274(98)00097-6
- Fromenty B, 1990, Dual effect of amiodarone on mitochondrial respiration. Initial protonophoric uncoupling effect followed by inhibition of the respiratory chain at the levels of complex I and complex II, J Pharmacol Exp Ther, 255, 1377, 10.1016/S0022-3565(25)22965-2 · DOI · Paper page
- 10.1073/pnas.93.8.3592 · DOI · Paper page
- Poucell S, 1984, Amiodarone‐associated phospholipidosis and fibrosis of the liver. Light, immunohistochemical, and electron microscopic studies, Gastroenterology, 86, 926, 10.1016/S0016-5085(24)05145-X · DOI
- 10.1055/s-2008-1040724 · DOI
- 10.1007/BF01312555 · doi:10.1007/bf01312555
- 10.1002/hep.21258 · DOI · Paper page
- 10.1055/s-0028-1085099 · doi:10.1055/s-0028-1085099
- 10.1136/bcr-2012-007411 · doi:10.1136/bcr-2012-007411
- 10.1016/j.bbmt.2009.07.014 · doi:10.1016/j.bbmt.2009.07.014
- 10.1007/s12185-013-1275-2 · DOI
- 10.1016/j.jhep.2013.07.039 · doi:10.1016/j.jhep.2013.07.039
- 10.1007/s00428-010-1004-7 · doi:10.1007/s00428-010-1004-7
- 10.1097/QAD.0b013e3283389e26 · DOI
- 10.1111/1751-2980.12177 · DOI
- 10.1016/j.ejso.2013.09.015 · DOI
- 10.1097/00005176-198601000-00008 · doi:10.1097/00005176-198601000-00008
- 10.1053/j.gastro.2006.07.006 · doi:10.1053/j.gastro.2006.07.006
- 10.1016/j.humpath.2003.10.017 · doi:10.1016/j.humpath.2003.10.017
- 10.1016/S0022-3476(80)80123-5 · doi:10.1016/s0022-3476(80)80123-5
- Morse CG, 2015, Nonalcoholic steatohepatitis and hepatic fibrosis in HIV‐1‐monoinfected adults with elevated aminotransferase levels on antiretroviral therapy, Clin Infect Dis, 60, 1569, 10.1093/cid/civ101 · DOI
- 10.1002/hep.24481 · DOI · Paper page
- 10.1002/hep.27157 · DOI · Paper page
- 10.1097/MPG.0b013e31821d6cfd · DOI
- 10.5009/gnl14184 · DOI
- 10.1007/s11894-012-0299-8 · DOI
- 10.1111/liv.13380 · DOI
- 10.1111/bjh.12558 · DOI · Paper page
- 10.1016/0168-8278(88)80027-8 · DOI
- 10.1097/PAS.0000000000000453 · DOI · Paper page
- 10.1111/liv.12899 · DOI
- 10.1097/00042737-200012030-00017 · DOI
- 10.1111/j.1478-3231.2006.01377.x · DOI · Paper page
Cited by
AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury
Fontana, R. J., Liou, I., Reuben, A., Suzuki, A., Fiel, M. I., Lee, W., & Navarro, V. (2023) · Hepatology · doi:10.1002/hep.32689 · Cited by 340
Drug induced liver injury: an update
Garcia-Cortes, M., Robles-Diaz, M., Stephens, C., Ortega-Alonso, A., Lucena, M. I., & Andrade, R. J. (2020) · Archives of Toxicology · doi:10.1007/s00204-020-02885-1 · Cited by 286
Drug-induced liver injury in older people
Lucena, M. I., Sanabria, J., García-Cortes, M., Stephens, C., & Andrade, R. J. (2020) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(20)30006-6 · Cited by 77
Hepatic Damage by Natural Remedies
Medina-Caliz, I., Gonzalez-Jimenez, A., Garcia-Cortes, M., Lucena, M. I., & Andrade, R. (2018) · Seminars in Liver Disease · doi:10.1055/s-0038-1623518 · Cited by 40
Validation of the revised electronic version of RUCAM for diagnosis of DILI in Chinese patients
Zhao, X., Wang, Y., Lai, R., Wang, X., Yu, Y., Li, M., Zhao, H., Ma, Z., Li, M., Guo, T., et al. (2024) · Hepatology Communications · doi:10.1097/hc9.0000000000000235 · Cited by 12
Metadata
- Authors
- Kleiner, D. E.
- Affiliations
- Post‐Mortem Section Laboratory of Pathology National Cancer Institute Bethesda MD USA
- ORCID
- Kleiner, David E.
- Venue
- Liver International
- Publisher
- Wiley
- Published
- 2017-09-19
- Volume
- 38
- Issue
- 2
- Pages
- 198-209
- ISSN
- 1478-3223
- 1478-3231
- Cited by
- 42
- References
- 4
- Language
- en
- Funders
- National Institutes of Health
- National Cancer Institute
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Histopathological challenges in suspected drug‐induced liver injury. https://app.cochat.ai/papers/10.1111/liv.13584
- The paper
- Kleiner, D. E. (2018). Histopathological challenges in suspected drug‐induced liver injury. Liver International. https://doi.org/10.1111/liv.13584
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.